The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins
Abstract
Malignant melanoma cells have been reported to be highly resistant to chemotherapeutic agents. To gain insight into the molecular mechanisms underlying chemotherapeutic drug resistance, we examined the role of the Bcl-2 family members Bcl-2 and Bax in cell death in the melanoma cell line G361 following stimulation with cisplatin (CDDP) or dacarbazine (DTIC). Trypan blue dye exclusion showed that both CDDP and DTIC induced death of G361 cells. Apoptotic and necrotic cell death could be distinguished by flow cytometry using combined staining with annexin V and 7-amino-actinomycin D (7-AAD). CDDP-induced cell death at a low concentration (0.6 micro g/ml) was mainly due to apoptosis (annexin V+/7-AAD-), while a mixture of apoptosis and secondary necrosis (annexin V+/7-AAD+) was found at a high concentration (6 micro g/ml). DTIC at the concentrations used induced only apoptosis. CDDP-induced apoptosis and secondary necrosis were accompanied by activation of caspase-3 and modulation of Bcl-2 family members Bcl-2 and Bax. On Western blotting Bax was seen to be upregulated with concomitant downregulation of Bcl-2. Flow cytometry, which enables measurement of protein at the single-cell level, revealed that Bcl-2+/Bax- cells were decreased, with a slight concomitant rise in Bcl-2-/Bax+ cells on stimulation with CDDP. These findings suggest that the chemotherapeutic agents CDDP and DTIC induce apoptosis and/or secondary necrosis depending on dose, probably involving the modulation of Bcl-2 family proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both DTIC and Temozolomide act through a common degradation product (MTIC).”
From Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields) (2009) · cites this paper as [16]
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Koopman, G., Reutelingsperger, C. P. M., Kuijten, G., Keehnen, R. M. J., Pals, S. T., & van Oers, M. H. J. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,687
Social controls on cell survival and cell death
RAFF, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,591
A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B
Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D., Timkey, T., Garcia-Calvo, M. M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17907 · Cited by 2,089
Koopman, G., Reutelingsperger, C., Kuijten, G., et al. (1994) · Blood · doi:10.1182/blood.v84.5.1415.bloodjournal8451415 · Cited by 2,068
The proto-oncogene Bcl-2 and its role in regulating apoptosis
Kroemer, G. (1997) · Nature Medicine · doi:10.1038/nm0697-614 · Cited by 1,739
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Intracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,249
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,048
Tsujimoto, Y., Gorham, J. D., Cossman, J., Jaffe, E. S., & Croce, C. M. (1985) · Science · doi:10.1126/science.3929382 · Cited by 990
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, W. R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 965
Mitochondria as regulators of apoptosis: doubt no more
Susín, S. A., Zamzami, N., & Kroemer, G. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00110-8 · Cited by 827
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
Jansen, B., Schlagbauer‐Wadl, H., Brown, B. D., Bryan, R. N., van Elsas, A., Müller, M., Wolff, K. S., Eichler, H., & Pehamberger, H. (1998) · Nature Medicine · doi:10.1038/nm0298-232 · Cited by 478
Miyashita, T., & Reed, J. C. (1992) · PubMed · Cited by 474
Bcl-2 and Bcl-XL Can Differentially Block Chemotherapy-Induced Cell Death
Simonian, P. L., Grillot, D., & Núñez, G. (1997) · Blood · doi:10.1182/blood.v90.3.1208 · Cited by 242
Drug-resistance in human melanoma
Helmbach, H., Rossmann, E., Kern, M. A., & Schadendorf, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1378 · Cited by 191
Mutagenic damage to mammalian cells by therapeutic alkylating agents
Sanderson, B. J. S., & Shield, A. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(96)00021-8 · Cited by 153
Franco, A. V., Zhang, X. D., Berkel, E. V., Sanders, J. E., Zhang, X. Y., Thomas, W. D., Nguyen, T. T., & Hersey, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5337 · Cited by 150
Trimmer, E. E., & Essigmann, J. M. (1999) · Essays in Biochemistry · doi:10.1042/bse0340191 · Cited by 127
Raisova, M., Bektas, M., Wieder, T., Daniel, P. T., Eberle, J., Orfanos, C. E., & Geilen, C. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01491-5 · Cited by 94
Komatsu, M., Tatum, L. M., Altman, N. H., Carraway, C. A. C., & Carraway, K. L. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4 · Cited by 90
Hérault, O., Colombat, P., Domenech, J., Degenne, M., Bremond, J.-L., Sensebé, L., Bernard, M., & Binet, C. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01203.x · Cited by 79
Microfluorometric investigations of chromatin structure
Cowden, R. R., & Curtis, S. K. (1981) · Histochemistry and Cell Biology · doi:10.1007/bf00496774 · Cited by 67
Lage, H., Helmbach, H., Dietel, M., & Schadendorf, D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0947 · Cited by 64
Helmbach, H., Kern, M. A., Rossmann, E., Renz, K., Kissel, C. K., Gschwendt, B., & Schadendorf, D. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01786.x · Cited by 61
European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma
Eggermont, A. M. M., & Gore, M. E. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.34117 · Cited by 57
Classical chemotherapy for metastatic melanoma
Becker, J. C., Kämpgen, E., & Bröcker, E.-B. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00690.x · Cited by 51
Takada, E., Toyota, H., Suzuki, J., & Mizuguchi, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1641 · Cited by 50
Self-citationBcl-xL confers multi-drug resistance in several squamous cell carcinoma cell lines
Noutomi, T., Chiba, H., Itoh, M., Toyota, H., & Mizuguchi, J. (2002) · Oral Oncology · doi:10.1016/s1368-8375(00)00098-1 · Cited by 43
Self-citationPérez, J. M., Montero, E. I., González, A. M., Álvarez-Valdés, A., Alonso, C., & Navarro‐Ranninger, C. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00143-9 · Cited by 42
Pattanapanyasat, K., Thaithong, S., Kyle, D. E., Udomsangpetch, R., Yongvanitchit, K., Hider, R. C., & Webster, H. K. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19970101)27:1 · Cited by 35
Participation of Bax-α in IFN-α-Mediated Apoptosis in Daudi B Lymphoma Cells
Yanase, N., Takada, E., Yoshihama, I., Ikegami, H., & Mizuguchi, J. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.855 · Cited by 29
Self-citationThe apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.
Felice, V. D., Lauricella, M., Giuliano, M., Emanuele, S., Vento, R., & Tesoriere, G. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.2.225 · Cited by 27
Microfluorometric investigations of chromatin structure
Cowden, R. R., & Curtis, S. K. (1981) · Histochemistry and Cell Biology · doi:10.1007/bf00501781 · Cited by 27
Skin cancer screening and surveillance
Osborne, J. E. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04847.x · Cited by 18
Kim, R., Ohi, Y., Inoue, H., & Toge, T. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.4.751 · Cited by 15
Itoh, M., Noutomi, T., Chiba, H., & Mizuguchi, J. (2002) · Oral Oncology · doi:10.1016/s1368-8375(02)00047-7 · Cited by 13
Self-citationAdjuvant therapy of malignant melanoma: is there a choice?
Retsas, S. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00099-3 · Cited by 12
Research works printed but not linked: 5
- Di Felice, 1998, Int J Oncol, 13, 225
- Kim, 1999, Int J Oncol, 15, 751
- Miyashita, 1992, Cancer Res, 52, 5407
- Searle, 1982, Pathol Annu, 17, 229
- Eguchi, 1997, Cancer Res, 57, 1835
Cited by
Sorted by citations
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
López-Novoa, J. M., Quirós, Y., Vicente-Vicente, L., Morales, A. I., & López-Hernández, F. J. (2010) · Kidney International · doi:10.1038/ki.2010.337 · Cited by 756
Kirson, E. D., Schneiderman, R. S., Dbalý, V., Tovaryš, F., Vymazal, J., Itzhaki, A., Mordechovich, D., Gurvich, Z., Shmueli, E., Goldsher, D., et al. (2009) · BMC Medical Physics · doi:10.1186/1756-6649-9-1 · Cited by 224
AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells
Harhaji-Trajkovic, L. M., Vilimanovich, U., Kravic‐Stevovic, T., Bumbaširević, V., & Trajković, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00663.x · Cited by 189
Yang, W., Vethanayagam, R. R., Dong, Y., Cai, Q., & Hu, B. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.081 · Cited by 115
Shi, Y., Zhai, H., Wang, X., Han, Z., Liu, C., Lan, M., Du, J.-P., Guo, C., Zhang, Y., Wu, K., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.009 · Cited by 111
Metadata
- Authors
- Shibuya, H., Kato, Y., Saito, M., Isobe, T., Tsuboi, R., Koga, M., Toyota, H., & Mizuguchi, J.
- Affiliations
- Tokyo Medical University (JP)
- Tokyo Medical University Hospital (JP)
- Corresponding author
- Mizuguchi, Junichiro
- Venue
- Melanoma Research
- Published
- 2003-10
- Volume
- 13
- Issue
- 5
- Pages
- 457-464
- ISSN
- 0960-8931 (ISSN-L)
- OpenAlex
- W2000352929
- Cited by
- 46
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 1 · 2021: 2 · 2019: 1 · 2017: 1 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Melanoma Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- melanoma, apoptosis, secondary necrosis, Bcl-2 family proteins, Bcl-2, Bax, cisplatin, dacarbazine, chemoresistance, caspase-3, dose-dependent cell death
- MeSH terms
- Antineoplastic Agents, Cell Survival, Cisplatin, Dacarbazine, Dactinomycin, Dose-Response Relationship, Drug, Coloring Agents, Enzyme Activation, Flow Cytometry, Fluorescent Dyes, Humans, Melanoma, Necrosis, Time Factors, Trypan Blue, Blotting, Western, Down-Regulation, Up-Regulation, Cell Death, Apoptosis, Annexin A5, Antineoplastic Agents, Alkylating, Proto-Oncogene Proteins c-bcl-2, Caspases, Cell Line, Tumor, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review